Jeffrey Leiden Insider Profile

4 Followers
Jeffrey Leiden, EC, Director at Vertex Pharmaceuticals, holds 10.43K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 6.00K shares in Quest Diagnostics (Ticker: DGX), holds 210.04K shares in Abbott Laboratories (Ticker: ABT).
tipranks
Jeffrey Leiden

Jeffrey Leiden
Vertex Pharmaceuticals (VRTX)
EC, Director

Ranked #57,878 out of 99,335 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-5.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$31M
79.84%
17.04%
3.13%
A breakdown of Jeffrey Leiden's holdings

Insider Roles

Abbott Laboratories
(ABT)
President & COO, Director
Vertex Pharmaceuticals
(VRTX)
EC, Director
Quest Diagnostics
(DGX)
Director
Roles that Jeffrey Leiden holds in companies

Most Profitable Insider Trade

Stock:
Quest Diagnostics
(DGX)
Rating:Informative Sell
Date:May 30, 2018 - May 30, 2019
Return:+9.40%
The most profitable trade made by Jeffrey Leiden

Jeffrey Leiden's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vertex Pharmaceuticals
Sep 04, 2024
EC, Director
Uninformative Sell
1.89M
$5.23M
Quest Diagnostics
May 30, 2018
Director
Informative Sell
173.62K
$961.02K
Abbott Laboratories
President & COO, Director
$24.53M
List of latest transactions for each holding click on a transaction to see Jeffrey Leiden's performance on stock

Jeffrey Leiden insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Leiden?
The percentage of profitable transactions made by Jeffrey Leiden is 25%.
    What is the average return per transaction made by Jeffrey Leiden?
    The average return per transaction made by Jeffrey Leiden is -5.60%.
      What stocks does Jeffrey Leiden hold?
      Jeffrey Leiden holds: VRTX, DGX, ABT stocks.
        What was Jeffrey Leiden’s latest transaction?
        Jeffrey Leiden latest transaction was an Uninformative Sell of $1.89M.
          What was Jeffrey Leiden's most profitable transaction?
          Jeffrey Leiden’s most profitable transaction was an Informative Sell of DGX stock on May 30, 2018. The return on the trade was 9.40%.
            What is Jeffrey Leiden's role in Vertex Pharmaceuticals?
            Jeffrey Leiden's role in Vertex Pharmaceuticals is EC, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.